OraSure Technologies | OSUR - 资产

股票价格
3.08
每天变化
0.13 4.41%
每月一次
9.22%
每年
-15.85%
Q1 预测
2.86


金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 217.7M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


资产 更改 日
Agilent USD 12.81B 86M 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Cerus USD 215.18M 2.11M 2025-09
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.43B 224M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Exact Sciences USD 5.86B 39.38M 2025-12
Hologic USD 9.18B 165.8M 2025-12
Illumina USD 6.64B 467M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
OraSure Technologies USD 403.17M 19.93M 2025-12
Quidel USD 5.77B 94.2M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
STAAR Surgical USD 451.68M 4.68M 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Trinity Biotech USD 103.71M 4.08M 2025-09
Waters USD 5.08B 221.41M 2025-12